Viewing Study NCT00219557


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2026-01-02 @ 9:44 AM
Study NCT ID: NCT00219557
Status: COMPLETED
Last Update Posted: 2019-05-14
First Post: 2005-09-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A4061016
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators